UBS AM’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $4.76K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.02M | Buy |
|
|||||
|
2024
Q3 | $2.94M | Buy |
|
|||||
|
2024
Q2 | $2.21M | Buy |
|
|||||
|
2024
Q1 | $1.13M | Hold |
|
|||||
|
2023
Q4 | $681K | Buy |
|
|||||
|
2023
Q3 | $353K | Sell |
|
|||||
|
2023
Q2 | $732K | Hold |
|
|||||
|
2023
Q1 | $732K | Hold |
|
|||||
|
2022
Q4 | $823K | Hold |
|
|||||
|
2022
Q3 | $645K | Buy |
|
|||||
|
2022
Q2 | $306K | Buy |
|
|||||
|
2022
Q1 | $436K | Hold |
|
|||||
|
2021
Q4 | $469K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $431K | Buy |
|
|||||
|
2020
Q4 | $430K | Buy |
|